BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

625 related articles for article (PubMed ID: 30526315)

  • 1. Ion channels as therapeutic antibody targets.
    Hutchings CJ; Colussi P; Clark TG
    MAbs; 2019; 11(2):265-296. PubMed ID: 30526315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of therapeutic antibodies to G protein-coupled receptors and ion channels: Opportunities, challenges and their therapeutic potential in respiratory diseases.
    Douthwaite JA; Finch DK; Mustelin T; Wilkinson TC
    Pharmacol Ther; 2017 Jan; 169():113-123. PubMed ID: 27153991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody therapeutics targeting ion channels: are we there yet?
    Sun H; Li M
    Acta Pharmacol Sin; 2013 Feb; 34(2):199-204. PubMed ID: 23381110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Introduction to the Theme "Ion Channels and Neuropharmacology: From the Past to the Future".
    Dolphin AC; Insel PA; Blaschke TF; Meyer UA
    Annu Rev Pharmacol Toxicol; 2020 Jan; 60():1-6. PubMed ID: 31914892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of functional antibodies targeting ion channels.
    Wilkinson TC; Gardener MJ; Williams WA
    J Biomol Screen; 2015 Apr; 20(4):454-67. PubMed ID: 25473082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRAC channels as targets for drug discovery and development.
    Stauderman KA
    Cell Calcium; 2018 Sep; 74():147-159. PubMed ID: 30075400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generating therapeutic monoclonal antibodies to complex multi-spanning membrane targets: Overcoming the antigen challenge and enabling discovery strategies.
    Dodd R; Schofield DJ; Wilkinson T; Britton ZT
    Methods; 2020 Aug; 180():111-126. PubMed ID: 32422249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploiting high-throughput ion channel screening technologies in integrated drug discovery.
    Treherne JM
    Curr Pharm Des; 2006; 12(4):397-406. PubMed ID: 16472135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulating ion channel function with antibodies and nanobodies.
    Stortelers C; Pinto-Espinoza C; Van Hoorick D; Koch-Nolte F
    Curr Opin Immunol; 2018 Jun; 52():18-26. PubMed ID: 29579624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physiologically-based modeling of monoclonal antibody pharmacokinetics in drug discovery and development.
    Glassman PM; Balthasar JP
    Drug Metab Pharmacokinet; 2019 Feb; 34(1):3-13. PubMed ID: 30522890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies and venom peptides: new modalities for ion channels.
    Wulff H; Christophersen P; Colussi P; Chandy KG; Yarov-Yarovoy V
    Nat Rev Drug Discov; 2019 May; 18(5):339-357. PubMed ID: 30728472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of functional monoclonal antibodies targeting G-protein-coupled receptors and ion channels.
    Wilkinson TC
    Biochem Soc Trans; 2016 Jun; 44(3):831-7. PubMed ID: 27284048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic scope of modulation of non-voltage-gated cation channels.
    Li S; Gosling M; Poll CT; Westwick J; Cox B
    Drug Discov Today; 2005 Jan; 10(2):129-37. PubMed ID: 15718162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic scope of modulation of non-voltage-gated cation channels.
    Li S; Gosling M; Poll CT; Westwick J; Cox B
    Drug Discov Today; 2004 Dec; 9(24):1045-54. PubMed ID: 15582793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ion Channels in Drug Discovery and Safety Pharmacology.
    Imbrici P; Nicolotti O; Leonetti F; Conte D; Liantonio A
    Methods Mol Biol; 2018; 1800():313-326. PubMed ID: 29934900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening Strategies for the Discovery of Ion Channel Monoclonal Antibodies.
    Colley CS; England E; Linley JE; Wilkinson TCI
    Curr Protoc Pharmacol; 2018 Sep; 82(1):e44. PubMed ID: 30168908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of Automated Technologies to Ion Channel Drug Discovery.
    Picones A; Loza-Huerta A; Segura-Chama P; Lara-Figueroa CO
    Adv Protein Chem Struct Biol; 2016; 104():357-378. PubMed ID: 27038379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ion channels as medicinal targets of biological toxins: the impact of automated patch-clamp electrophysiology.
    Picones A
    Curr Top Med Chem; 2015; 15(7):631-7. PubMed ID: 25751269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High throughput assay technologies for ion channel drug discovery.
    Zheng W; Spencer RH; Kiss L
    Assay Drug Dev Technol; 2004 Oct; 2(5):543-52. PubMed ID: 15671652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How to rekindle drug discovery process through integrative therapeutic targeting?
    Vaidya A; Roy A; Chaguturu R
    Expert Opin Drug Discov; 2018 Oct; 13(10):893-898. PubMed ID: 30146919
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 32.